A CASE OF MODY 2 - ASSOCIATED HYPERGLYCEMIA
DIAGNOSED AS GESTATIONAL DIABETES
Chakarova N.1, Balabanski L.2,3, Dimova R.1, Tsarkova P.1, Tankova T.1
*Corresponding Author: Nevena Chakarova, MD, PhD, Department of Endocrinology Medical University
Sofia, 1431 Sofia, 2 Zdrave Str., e-mail: veni_chakarova@abv.bg, ORCID ID 0000-0001-7606-5060
page: 4
|
|
REFERENCES
1. Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset
diabetes of the young (MODY): an update. J Pediatr
Endocrinol Metab. 2015; 28(3-4):251-63. doi:
10.1515/jpem-2014-0384. PMID: 25581748.
2. Nkonge KM, Nkonge DK, Nkonge TN. The epidemiology,
molecular pathogenesis, diagnosis, and
treatment of maturity-onset diabetes of the young
(MODY). Clin Diabetes Endocrinol. 2020; 6:20.
https://doi.org/10.1186/s40842-020-00112-5.
3. Juszczak A, Pryse R, Schuman A, Owen KR. When
to consider a diagnosis of MODY at the presentation
of diabetes: aetiology matters for correct management.
Br J Gen Pract. 2016; 66(647): e457-e459. doi:
10.3399/bjgp16X685537.
4. Murphy R. Monogenic diabetes and pregnancy.
Obstet Med. 2015; 8(3): 114-120. doi:
10.1177/1753495X15590713.
5. Misra S, Dornhorst A. Gestational Diabetes Mellitus:
Primum Non Nocere. Diabetes Care. 2012; 35(9):
1811-1813. doi: 10.2337/dc12-0689.
6. Chang X, Wang K. wANNOVAR: annotating genetic
variants for personal genomes via the web. J
Med Genet. 2012 Jul; 49(7): 433-6. doi: 10.1136/
jmedgenet-2012-100918.
7. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-
Foster J et al; ACMG Laboratory Quality Assurance
Committee. Standards and guidelines for the interpretation
of sequence variants: a joint consensus
recommendation of the American College of Medical
Genetics and Genomics and the Association for
Molecular Pathology. Genet Med. 2015 May; 17(5):
405-24. doi: 10.1038/gim.2015.30.
8. Fenton TR, Kim JH. A systematic review and metaanalysis
to revise the Fenton growth chart for preterm
infants. BMC Pediatr. 2013; 13:59. https://doi.
org/10.1186/1471-2431-13-59.
9. Gloyn AL, Odili S, Zelent D, Buettger C, Castleden
HAJ, Steele AM et al. Insights into the structure and
regulation of glucokinase from a novel mutation
(V62M), which causes maturity-onset diabetes of
the young. J Biol Chem. 2005; 280(14): 14105-13.
doi: 10.1074/jbc.M413146200
10. Shepherd M, Shields B, Hammersley S, Hudson M,
McDonald TJ, Colclough K et al. Systematic Population
Screening, Using Biomarkers and Genetic Testing,
Identifies 2.5% of the U.K. Pediatric Diabetes Population
With Monogenic Diabetes. Diabetes Care. 2016
Nov; 39(11): 1879-1888. doi: 10.2337/dc16-0645.
11. Aloi C, Salina A, Minuto N, Tallone R, Lugani F,
Mascagni A et al. Glucokinase mutations in pediatric
patients with impaired fasting glucose. Acta Diabetol.
2017 Oct; 54(10): 913-923. doi: 10.1007/s00592-017-
1021-y.
12. Osbak KK, Colclough K, Saint-Martin C, Beer NL,
Bellanné-Chantelot C, Ellard S, Gloyn AL. Update on
mutations in glucokinase (GCK), which cause maturity-
onset diabetes of the young, permanent neonatal
diabetes, and hyperinsulinemic hypoglycemia Hum
Mutat. 2009 Nov; 30(11): 1512-26. doi: 10.1002/
humu.21110.
13. Arden C, Trainer A, de la Iglesia N, Scougall ET,
Gloyn AL, Lange AJ et al. Cell biological assessment
of glucokinase mutations V62M and G72R in
pancreatic beta-cells: evidence for cellular instability
of catalytic activity. Diabetes. 2007 Jul; 56(7): 1773-
82. doi: 10.2337/db06-1151.
14. Ralph EC, Sun S. Biochemical characterization of
MODY2 glucokinase variants V62M and G72R reveals
reduced enzymatic activities relative to wild
type. Biochemistry. 2009 Mar 24; 48(11): 2514-21.
doi: 10.1021/bi900020n.
15. Rhea JM, Molinaro R. Pathology consultation on
HbA(1c) methods and interferences. Am J Clin Pathol.
2014 Jan; 141(1): 5-16. doi: 10.1309/AJCPQ23GTTMLAEVL.
|
|
|
|
 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
